Výsledky vyhledávání - "János Földes"

Biologic Markers in Blood Reflecting Thyroid Hormone Effect at Peripheral Tissue Level in Patients Receiving Levothyroxine Replacement for Hypothyroidism

Autor: G Tarján, F. Varga, Béla Büki, János Földes, C Bános, János Németh

Publikováno v: Experimental and Clinical Endocrinology & Diabetes. 99:129-133

Plasma fibronectin, serum procollagen-III-peptide and sex-hormone binding globulin as not specific markers of thyroid hormone effect at peripheral tissue level were determined and their values were related with serum levels of TSH, free-thyroxine and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebeeb0a4f483e67c22b7e559bf5f48d5
https://doi.org/10.1055/s-0029-1211153

Zobrazit plný text záznamu

The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses

Autor: G. Szilágyi, K. I. Takáts, I. Földes, János Földes, E. Rimanóczy, L. Kovács, A. Ferencz, Miklós Góth, Orsolya Dohán, István Szabolcs

Publikováno v: Europe PubMed Central

The objective of the study was to investigate the efficacy of long term thyrostatic versus radioiodine treatment of hyperthyroidism in old age. Our study is a retrospective analysis of the therapeutical outcome in 66 patients over 60 years of age wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae2bc6d0f4b645b2be78afe5ecdb703
https://doi.org/10.1055/s-0029-1212076

Zobrazit plný text záznamu

The investigation of galectin-3 in diseases of the thyroid gland

Autor: Rita Beáta Kovács, Gábor Winkler, János Földes, Zoltán Sápi, Miklós Bodó

Publikováno v: European Journal of Endocrinology. :449-453

OBJECTIVE: Malignant tumors of the thyroid gland exhibit a variety of histopathologies and clinical behavior. Immune markers are gaining more and more importance in diagnostic pathology, especially in the differential diagnostics and in the grading o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6862d29ce0bea70de4a73e754c72187c
https://doi.org/10.1530/eje.0.1490449

Zobrazit plný text záznamu

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

Autor: P. Lakatos, Zsolt Nagy, A. Bossanyi, Gábor Speer, János Földes, Cs. Horvath, István Takács, L. Kiss

Publikováno v: Zeitschrift für Rheumatologie. 59:I48-I52

We studied the effect of alphacalcidol (1-alpha-hydroxycholecalciferol) on bone metabolism in patients who were placed on glucocorticoid therapy. We selected 41 women (age: 32-52 yrs) who were recently diagnosed with systemic lupus erythematodes, mul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64501494ad7c9fc6f97d4a84c5cb9cde
https://doi.org/10.1007/s003930070040

Zobrazit plný text záznamu

Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?

Autor: János Földes, Miklós Szathmári, G. Tarján, I. Krasznai, Cs. Horvath, F. Varga

Publikováno v: Clinical Endocrinology. 39:521-527

Summary OBJECTIVE The aim of the present study was to elucidate whether endogenous subclinical hyperthyroidism due to a solitary autonomously functioning thyroid nodule affects bone metabolism and is a risk factor for osteoporosis. DESIGN In a cross-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591e7dbec30bfc126484c868de700c22
https://doi.org/10.1111/j.1365-2265.1993.tb02403.x

Zobrazit plný text záznamu

[Subclinical hypothyroidism and arteriosclerosis]

Autor: János, Földes, Csaba, Bános, Gábor, Winkler

Publikováno v: Orvosi hetilap. 145(31)

Overt hypothyroidism predisposes to the development of atherosclerosis. Recent data indicate that subclinical hypothyroidism is also associated with enhanced risk for arteriosclerotic cardiovascular disease, which could be attributed to multiple mech

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7ac240a0e0ab72895f0e261819827253
https://pubmed.ncbi.nlm.nih.gov/15384857

Zobrazit plný text záznamu

Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism

Autor: Gábor Speer, Paula H. Stern, Zsolt Nagy, János Földes, Peter L. Lakatos, Subburaman Mohan, David J. Baylink, Csaba Horváth, István Takács

Publikováno v: Thyroid : official journal of the American Thyroid Association. 10(5)

The mechanism by which thyroid hormones promote bone growth has not yet been elucidated. In vitro, thyroid hormones stimulate insulin-like growth factor-I (IGF-I) production by osteoblasts, which is important for the anabolic effects of the hormone o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f169c94be6a4e1e297ddb5071b5004d3
https://pubmed.ncbi.nlm.nih.gov/10884189

Zobrazit plný text záznamu

Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism

Autor: Júlia Zsadányi, Csaba Horváth, János Földes, Peter L. Lakatos

Publikováno v: European journal of endocrinology. 136(3)

Postmenopausal women with endogenous subclinical hyperthyroidism seem to have reduced bone mass, which does not correlate with serum thyroid hormone levels. Relative insufficiencies of IGF-I and dehydroepiandrosterone sulphate (DHEAS) might be additi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0638b55209d83811be1b9bfd7f02e409
https://pubmed.ncbi.nlm.nih.gov/9100552

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání